Huntsman CORP(HUN)Stock Analysis
AI analysis on 6,000+ stocks →Deep AI analysis on 6,000+ stocks →13F Pro Quality Score
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
HUN Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Huntsman CORP (HUN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HUN at 40.2/100 on a 32-signal composite quality model, placing it at rank #1,932 of 2,849 stocks — the bottom half of the AI-ranked universe. HUN scores in the top quartile across institutional flow (86.5), revenue scale (80.2). Areas of concern include revenue growth (22.3) and profitability (25.1), which score below median versus the broader universe. Based on the latest XBRL financial filings, Huntsman CORP reports trailing revenue of $1.4B, net income of $-53.0M, an operating margin of -1.1%. Top institutional holders of HUN by reported 13-F value include VANGUARD GROUP, VANGUARD GROUP, VANGUARD GROUP, based on the most recent SEC filings. HUN trades on the NYSE exchange and files with the SEC under CIK 1307954. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HUN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Huntsman CORP directly from SEC EDGAR.
Revenue
Q1 2026
$1.4B
Net Income
Q1 2026
$-53.0M
Free Cash Flow
Q1 2026
$-91.0M
Operating Margin
Q1 2026
-1.1%
D/E Ratio
Q1 2026
0.91
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-7.0% YoYNet Income
-381.2% YoYOperating Income
-256.0% YoYEPS (Diluted)
-389.5% YoYTotal Assets
-3.2% YoYTotal Debt
+39.1% YoYOp. Cash Flow
+38.3% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $5.68B -7.0% | $6.11B -23.8% | $8.02B -5.1% | $8.45B +40.5% | $6.02B -11.5% | $6.80B |
| Net Income | $-284.0M -381.2% | $101.0M -78.0% | $460.0M -56.0% | $1.04B +1.1% | $1.03B +84.0% | $562.0M |
| Operating Income | $-131.0M -256.0% | $84.0M -87.5% | $672.0M -15.5% | $795.0M +83.6% | $433.0M -7.7% | $469.0M |
| EPS (Diluted) | $-1.65 -389.5% | $0.57 -74.9% | $2.27 -51.9% | $4.72 +1.3% | $4.66 +91.0% | $2.44 |
| Total Assets | $7.01B -3.2% | $7.25B -11.8% | $8.22B -12.5% | $9.39B +7.8% | $8.71B +4.7% | $8.32B |
| Total Debt | $2.36B +39.1% | $1.70B -5.7% | $1.80B +15.4% | $1.56B -42.4% | $2.71B +4.3% | $2.60B |
| Operating Cash Flow | $289.0M +38.3% | $209.0M -77.1% | $914.0M -4.0% | $952.0M +276.3% | $253.0M -71.8% | $897.0M |
Track HUN with AI-powered research
10 AI analysts debate this stock daily. Free to start.
Available Research
13F Pro tracks comprehensive data for Huntsman CORP including:
Top Institutional Holders of HUN
VANGUARD GROUP INC
$498.0M18,121,322 shVANGUARD GROUP INC
$439.4M16,881,970 shVANGUARD GROUP INC
$423.2M16,838,484 shVANGUARD GROUP INC
$395.7M16,351,309 shVANGUARD GROUP INC
$373.1M16,384,232 shAllspring Global Investments Holdings, LLC
$341.6M13,121,474 shBlackRock Inc.
$324.6M14,255,845 shBlackRock Inc.
$322.2M12,379,717 shBlackRock, Inc.
$299.5M16,612,680 shVANGUARD GROUP INC
$297.2M16,482,011 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD GROUP INC | $498.0M | 18,121,322 |
| VANGUARD GROUP INC | $439.4M | 16,881,970 |
| VANGUARD GROUP INC | $423.2M | 16,838,484 |
| VANGUARD GROUP INC | $395.7M | 16,351,309 |
| VANGUARD GROUP INC | $373.1M | 16,384,232 |
| Allspring Global Investments Holdings, LLC | $341.6M | 13,121,474 |
| BlackRock Inc. | $324.6M | 14,255,845 |
| BlackRock Inc. | $322.2M | 12,379,717 |
| BlackRock, Inc. | $299.5M | 16,612,680 |
| VANGUARD GROUP INC | $297.2M | 16,482,011 |
More Healthcare Companies
View all Healthcare →Unlock Full Research for HUN
Get detailed financial analysis, insider activity, institutional flows, AI-powered debates, and quality rankings for Huntsman CORP and 6,000+ other companies.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HUN a good stock to buy?
13F Pro's AI-powered analysis of Huntsman CORP (HUN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HUN are available on the HUN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HUN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HUN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Huntsman CORP's investment landscape.